Human papillomavirus type 45 E7 is a transforming protein inducing retinoblastoma protein degradation and anchorage-independent cell cycle progression

This publication has 60 references indexed in Scilit:

• High-risk Human Papillomavirus E7 Oncoprotein Detection in Cervical Squamous Cell Carcinoma
  Clinical Cancer Research, 2007
• Human Papillomavirus Type 16 E7 Oncoprotein Associates with the Cullin 2 Ubiquitin Ligase Complex, Which Contributes to Degradation of the Retinoblastoma Tumor Suppressor
  Journal of Virology, 2007
• Human Papillomavirus Genotype Distribution in Low-Grade Cervical Lesions: Comparison by Geographic Region and with Cervical Cancer
  Cancer Epidemiology, Biomarkers & Prevention, 2005
• Against which human papillomavirus types shall we vaccinate and screen? the international perspective
  International Journal of Cancer, 2004
• Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis
  British Journal of Cancer, 2003
• Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer
  New England Journal of Medicine, 2003
• Papillomaviruses and cancer: from basic studies to clinical application
  Nature Reviews Cancer, 2002
• Both Rb and E7 are regulated by the ubiquitin proteasome pathway in HPV-containing cervical tumor cells
  Oncogene, 2001
• Immortalization of human cells and their malignant conversion by high risk human papillomavirus genotypes
  Seminars in Cancer Biology, 1999
• Long-term genome stability and minimal genotypic and phenotypic alterations in HPV16 E7-, but not E6-, immortalized human uroepithelial cells.
  Genes & Development, 1994